Assure Holdings Appoints Leading Orthopaedic and Spinal Surgeon Isador Lieberman to Medical Advisory Committee
DENVER, March 18, 2021 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (TSXV: IOM; OTCQB: ARHH), a provider...
News
Avricore Health Finalizes Agreement With Avrok Laboratories to Offer Real-Time Covid-19 Screening
The companies agree to offer HealthTab™ and COVID-19 rapid-antigen tests at resort locations, delivering fast and accurate results for travellers...
Dyadic Advancing Towards Human Clinical Trial of its SARS-CoV-2-S-RBD vaccine candidate, DYAI-100
Israel Institute for Biological Research (IIBR) reports successful challenge studies using human ACE2 transgenic mice vaccinated with SARS-CoV-2-S-RBD vaccine candidate...
Cancer Genetics Announces Roland J. Carrillo, PhD as Vice President of Business Development
RUTHERFORD, N.J., March 18, 2021 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (the “Company”) (Nasdaq: CGIX), an emerging leader in novel...
MEDIROM Healthcare Technologies Inc., Announces its latest Key Performance Indicators (KPIs)
NEW YORK, March 18, 2021 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Nasdaq CM:MRM), a Japanese based holistic healthcare Company...
APIE Therapeutics Prepares to Advance Pipeline Programs with Appointment of Robert Willette, Ph.D. as Chief Scientific Officer
Cary, NC, March 18, 2021 (GLOBE NEWSWIRE) -- APIE Therapeutics, a preclinical biopharma company pioneering microvasculature endothelium drug development by...
Helsinn publishes PROVe MF-CTCL study providing new data for mechlorethamine gel use in a real-world setting
Helsinn publishes PROVe MF-CTCL study providing new data for mechlorethamine gel use in a real-world setting Lugano, Switzerland, March 18,...
Eyenovia to Report Fourth Quarter and Full Year 2020 Results on Thursday, March 25
Company to host an investor conference call and webcast at 4:30pm ET on that dayNEW YORK, March 18, 2021 (GLOBE...
Celularity Announces Fast Track Designation by the FDA for its Natural Killer Cell Therapy CYNK-001 in the Treatment of Recurrent Glioblastoma Multiforme
FLORHAM PARK, N.J., March 18, 2021 (GLOBE NEWSWIRE) -- Celularity Inc. (“Celularity”), a clinical-stage biotechnology company, leading the next evolution...
ORYZON to Participate in Upcoming Virtual International Conferences in March and April
BIO-Europe Spring 2021Kempen Life Sciences Conference4th SACHS Annual Neuroscience Innovation Forum 2021 MADRID, Spain and CAMBRIDGE, Mass., March 18, 2021...
Positron Corp Retains Skyline Corporate Communications Group, LLC to Provide Investor Relations Services
Niagara Falls, NY , March 18, 2021 (GLOBE NEWSWIRE) -- Positron Corp (“Positron” or the “Company”) (OTC: POSC) is pleased...
Alimera Sciences to Participate in Benzinga Biotech Small Cap Conference
ATLANTA, March 18, 2021 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a pharmaceutical company that specializes in the...
Foghorn Therapeutics Provides Corporate Update
- FHD-286 Phase 1 data anticipated as early as year-end 2021 - FHD-609 IND submission on track for the second...
Entera Bio Ltd Announces Operating and Financial Results for the Fourth Quarter and Year Ended December 31, 2020
‒ Achieved Primary Endpoint in EB613 Phase 2 Clinical Trial ‒‒ Final Data, Including Bone Mineral Density, Expected in Q2:21...
ADMA Biologics to Report Fourth Quarter and Full Year 2020 Financial Results on March 25, 2021
Conference Call Scheduled for March 25, 2021 at 4:30 p.m. ETRAMSEY, N.J. and BOCA RATON, Fla., March 18, 2021 (GLOBE...
Vivos Therapeutics Schedules Fourth Quarter and Full Year 2020 Financial Results Conference Call for Thursday, March 25, 2021 at 5:00 pm ET
HIGHLANDS RANCH, Colo., March 18, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“the Company”) (NASDAQ: VVOS), a medical technology company...
Talis Appoints Jeryl Hilleman to Board of Directors
MENLO PARK, Calif., March 18, 2021 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a company dedicated to developing innovative...
Neoleukin Therapeutics to Host 2020 Financial Results Conference Call and Webcast on March 25, 2021
SEATTLE, March 18, 2021 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to...
Pyxis Oncology Announces Worldwide Licensing Agreement with Pfizer to Develop and Commercialize Multiple Antibody-Drug Conjugates
Pyxis expands developmental capabilities with license to two ADC programs and ADC technology platform toolkit developed by PfizerCAMBRIDGE, Mass., March...
Augmedix Announces Preliminary Fourth Quarter and Full Year 2020 Results
SAN FRANCISCO, March 18, 2021 (GLOBE NEWSWIRE) -- Augmedix, Inc. (OTC Pink: AUGX), a leading provider of remote medical documentation...